Despite Fast-paced Momentum, Clover Health Investments (CLOV) Is Still a Bargain Stock
Clover Health Investments (CLOV) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
CLOV Stock Alert: What to Know About Clover Health's Big Insider Buy
Clover Health (NASDAQ: CLOV ) co-founder and Executive Chairman Vivek Garipalli bought 531,700 shares of his troubled health insurance company this month. The executive now owns over 1.4 million shares.
Clover Health Investments, Corp. (CLOV) Hit a 52 Week High, Can the Run Continue?
Clover Health Investments (CLOV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Clover Health Investments (CLOV) Is Attractively Priced Despite Fast-paced Momentum
Clover Health Investments (CLOV) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
3 Healthcare AI Stocks Positioned for Potential Breakthroughs
Markets tanked on Monday because the Japanese central bank raised its interest rate to 0.25%. Interest rates were originally at a benchmark between 0 and 0.1, meaning a minor 15- to 25-basis-point increase had significant consequences for investors who were making margin calls with Yen.
Clover Health Investments, Corp. (CLOV) Q2 2024 Earnings Call Transcript
Clover Health Investments, Corp. (NASDAQ:CLOV ) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Ryan Schmidt - IR Andrew Toy - CEO Peter Kuipers - CFO Conference Call Participants Richard Close - Canaccord Genuity Inc. Jason Cassorla - Citigroup Whit Mayo - Leerink Partners Operator Ladies and gentlemen good afternoon, and welcome to the Clover Health Second Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
Clover Health Investments, Corp. (CLOV) Q2 Earnings and Revenues Beat Estimates
Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to loss of $0.06 per share a year ago.
Clover Health: New Business Model Is A Game Changer
Clover Health is making its AI-powered technology platform, Clover Assistant, available for other Medicare Advantage payors and providers under the brand name Counterpart Assistant. The new offering will employ a hybrid SaaS and shared-savings revenue model, with options for full capitation, which will boost its margins. Counterpart Assistant could be highly coveted due to its ability to diagnose chronic diseases early, which helps reduce healthcare costs for insurers.
